Bluechiip

Report your biosample audit trail and manage efficient workflows down to -196°C
Bluechiip
Operating

Bluechiip has developed and patented a technology that combines secure wireless sample ID tracking with integrated temperature reading for use in extreme environments such as Biobanks. It works reliably in temperatures from -196°C to over +100°C and it is not affected by ionising radiation or frost buildup. Based on MEMS technology, the Bluechiip tag contains no electronics and so, it is impervious to autoclave, gamma sterilisation, humidification, centrifuging and cryogenic storage unlike typical RFID. Compared to traditional tracking technologies like labels or barcodes, Bluechiip does not require line-of-sight for the readings. Therefore, it can be read through ice buildup. The Bluechiip tag can be embedded into storage products such as vials or blood bags and can't be detached like labels. Easy identification, along with any associated information from the tag can be detected by a reader. The tag has a unique hard-coded ID at the point of manufacture guaranteeing non-duplicates . Unlike any other tracking methods, the Bluechiip technology can sense the temperature of each item a tag is attached to. This technology is particularly important for industries such as the $2b biopreservation and cryopreservation market, which processes more than 300 million samples per year of tissue, stem cells, blood, reagents..., for industries such as pharmaceuticals, IVF, research, diagnostics and clinical trials. It also has applications in cold chain logistics, food, manufacturing, security and defence. Bluechiip innovative technology is a proud enabler for the Circular Economy helping to close loops in several industries.

Investors
Investor

Melbourne Angels

Images
Taken on 2020-09
Blog Posts
29th October, 2021
Quarterly Activities/Appendix 4C Cash Flow Report

Quarterly Activities/Appendix 4C Cash Flow Report Download September 2021 cash flow report and activ...

28th October, 2021
Open Briefing interview with MD Andrew McLellan

Open Briefing interview with MD Andrew McLellan License and Development Agreement with FUJIFILM Irvi...

25th October, 2021
Bluechiip signs License and Development Agreement with US-based Fujifilm Irvine Scientific

Read the official ASX announcement by clicking here. The transcript can be found below: Bluechiip Li...

24th October, 2021
2021 Notice of Annual General Meeting and Proxy Form

In the link below there are the following documents relating to the 2021 Annual General Meeting of B...

4th October, 2021
2021 Annual General Meeting – Online – 25th of November 10am

ASX announcement 2021 Annual General Meeting Date Bluechiip Limited (ASX: BCT) advises that its 2021...

28th June, 2021
Open Briefing Interview with MD Andrew McLellan – June 2021

Read the latest Open Briefing Interview with MD Andrew McLellan by clicking HERE

24th June, 2021
Bluechiip and Labcon reach $US1.6M settlement

Download the ASX announcement by clicking here

27th May, 2021
Bluechiip’s BoxTracker™ Wins ISBER 2021 Outstanding New Product Award

The International Society for Biological and Environmental Repositories (ISBER) – the leading networ...

25th May, 2021
Bluechiip’s BoxTracker™ Wins ISBER 2021 Outstanding New Product Award

Bluechiip is proud to announce that Bluechiip’s BoxTracker™ won the ISBER 2021 Outstanding New Produ...

29th April, 2021
Quarterly Activity Report and Appendix 4C – March 2021

Read the full Quarterly Activity Report and Appendix 4C ASX announcement HERE ACTIVITIES REPORT FOR ...

 Location
Melbourne
 People
No information available.
 Tags
#biomedicine
#biotech
#data
#medtech
 Feedback